T2 Biosystems, Inc. (TTOO)
0.0008
0.00 (0.00%)
USD |
OTCM |
Nov 19, 16:00
T2 Biosystems Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | -0.026M |
| September 30, 2023 | -0.013M |
| June 30, 2023 | -0.033M |
| March 31, 2023 | -0.12M |
| December 31, 2022 | -0.036M |
| September 30, 2022 | -0.126M |
| June 30, 2022 | 9.85M |
| March 31, 2022 | -0.029M |
| December 31, 2021 | 9.801M |
| September 30, 2021 | 0.042M |
| June 30, 2021 | 12.40M |
| March 31, 2021 | 2.553M |
| December 31, 2020 | 6.372M |
| September 30, 2020 | -33.26M |
| June 30, 2020 | -9.303M |
| March 31, 2020 | -0.067M |
| December 31, 2019 | -0.026M |
| September 30, 2019 | -0.291M |
| June 30, 2019 | -0.25M |
| March 31, 2019 | -0.194M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.357M |
| September 30, 2018 | -0.351M |
| June 30, 2018 | -0.543M |
| March 31, 2018 | -0.056M |
| December 31, 2017 | 0.125M |
| September 30, 2017 | -0.133M |
| June 30, 2017 | -0.874M |
| March 31, 2017 | -1.594M |
| December 31, 2016 | -0.893M |
| September 30, 2016 | -1.421M |
| June 30, 2016 | -1.015M |
| March 31, 2016 | -2.158M |
| December 31, 2015 | -1.874M |
| September 30, 2015 | -1.916M |
| June 30, 2015 | -2.644M |
| March 31, 2015 | -1.46M |
| December 31, 2014 | -1.045M |
| September 30, 2014 | -0.531M |
| June 30, 2014 | -0.245M |
| March 31, 2014 | -0.263M |
| December 31, 2013 | -0.063M |
| September 30, 2013 | -0.03M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ABVC BioPharma, Inc. | -0.0235M |
| Anika Therapeutics, Inc. | -1.756M |
| Perspective Therapeutics, Inc. | 23.73M |
| MiMedx Group, Inc. | -0.193M |
| Abbott Laboratories | -385.00M |